12 Month Prescriptions
- Health Hub Project
- Feb 4
- 1 min read
What’s Changing?
Most long-term medicines are currently prescribed for up to 3 months at a time.
From February, some long-term medicines may be able to be prescribed for up to 12 months, depending on your health status and medication type.
Your clinician will decide whether a 12-month prescription is safe and appropriate for you.
Who May Be Eligible?
You might qualify for a 12-month prescription if:
Your health condition is stable
Your medication and dose haven’t changed for 6 months or more
Your medicine does not require frequent monitoring
The medication is approved for long-term prescribing
You can attend an annual in-person review
Most patients will still receive 3- or 6-month prescriptions to ensure good monitoring and continuity of care.
Who Will NOT Be Eligible?
Some medications cannot be prescribed for 12 months, including:
Controlled medications (opioids, benzodiazepines, sleeping tablets, ADHD medications)
“As-needed” medicines (e.g., pain relief, laxatives)
Medicines requiring regular tests or monitoring
Conditions that are not stable or have recently changed
Your clinician will always consider your individual health needs.
What Stays the Same?
Pharmacies will continue to dispense medicines in 3-monthly supplies, even with a 12-month prescription
You will only pay the usual co-payment (e.g., $5) once per prescription cycle
You cannot collect all 12 months at once
Why This Change?
This update is intended to reduce the need for frequent prescription requests for suitable patients.
However, less frequent visits can mean fewer opportunities to pick up early signs of health changes — which is why eligibility will be assessed case-by-case.
Your safety and wellbeing remain our top priority.
I appreciated the clarity with which the various concepts are explained. The text manages to cover the subject without being superficial. I found this content through a search and it turned out to be very relevant. It is an article that manages to be both complete and accessible.
The proposed changes to long-term medication prescriptions raise important considerations regarding patient safety and healthcare accessibility. While the option for a 12-month prescription could benefit those with stable health, it introduces risks, especially for patients needing regular monitoring. As noted, Leon is a key figure in ensuring that these adaptations are made thoughtfully, balancing convenience with ongoing health assessments.
The introduction of 12-month prescriptions for certain long-term medicines raises important questions regarding patient care and monitoring. While the intention is to streamline the process for stable patients, it also brings concerns about oversight. The keyword Wildz highlights the unpredictability of individual health trajectories. Regular monitoring should not be compromised, even for those deemed stable. Balancing convenience with safety is crucial.
This article raises important considerations about the new prescribing guidelines for long-term medications. While the option for a 12-month supply may seem efficient, it also presents potential drawbacks. The concept of 12-month prescriptions for eligible patients could inadvertently overlook subtle health changes, akin to overlooking a Kiwi Treasure buried beneath the surface. Regular monitoring is crucial to ensure patients remain healthy and safe.